Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
57 studies found for:    MAO-B
Show Display Options
Rank Status Study
1 Terminated MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Safinamide, MAO-B inhibitor;   Drug: Placebo
2 Recruiting Detecting Central and Peripheral Biomarkers in MDD
Condition: Major Depressive Disorder
Intervention: Other: phenelzine treatment
3 Completed A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers
Condition: Alzheimer Disease, Healthy Volunteer
Interventions: Drug: 11C-L-deprenyl-D2;   Drug: RO4602522
4 Completed Multi Dose Effects of a Berry Extract Upon Moodand Cognition in Healthy Young Adults
Condition: Healthy
Intervention: Dietary Supplement: Fresh berry extract.
5 Enrolling by invitation Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.
Condition: Parkinson's Disease
Intervention: Drug: Rasagiline
6 Unknown  The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: placebo;   Drug: rasagiline
7 Completed
Has Results
Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
Condition: Parkinson's Disease
Intervention: Drug: orally disintegrating selegiline (Zelapar)
8 Completed Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
Condition: Parkinson's Disease
Intervention: Drug: Safinamide
9 Completed Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Safinimide 50-100 mg/day;   Drug: Matching Placebo
10 Completed Physiological, Cognitive and Cerebral Activity Changes as a Function of Cigarette Smoking (With or Without Nicotine) and Tobacco Abstinence
Condition: Smoking Cessation
Intervention:
11 Unknown  Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease
Conditions: Sleep Disturbances;   Parkinsons's Disease
Interventions: Drug: Rasagiline;   Drug: Placebo
12 Completed The Effect Of Berry Polyphenols On Human Behaviour
Condition: Healthy
Interventions: Dietary Supplement: Berry Polyphenols;   Dietary Supplement: Placebo
13 Active, not recruiting Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
Condition: Nicotine Dependence
Interventions: Drug: Nicotine Patch;   Drug: Moclobemide
14 Completed A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Rasagiline
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline;   Drug: Placebo
15 Completed MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
Condition: Idiopathic Parkinson's Disease
Intervention: Drug: Safinamide (as add-on therapy)
16 Unknown  Rasagiline for Gait Treatment
Condition: Parkinson Disease
Intervention:
17 Terminated Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rasagiline
18 Not yet recruiting Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study
Conditions: Drug-naïve Patients With Parkinson's Disease;   Apathy
Interventions: Drug: AZILECT®;   Drug: Placebo
19 Completed Contribution of Wine Components on Hydroxytyrosol Body Concentrations and Biological Effects
Condition: Contribution of Wine Components in Hydroxytyrosol Formation
Interventions: Dietary Supplement: Ethanol;   Other: Water;   Dietary Supplement: Alcoholized wine;   Dietary Supplement: De-alcoholized wine
20 Unknown  The Effect of Rasagiline on Cognition in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years